Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase (PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid (Abeta) was directly involved in PAK signaling deficits and drebrin loss in Abeta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher Abeta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ oligomers reduce activity of LIMK, which in turns leads to dephosphorylated, active cofilin, depolymerization of actin filaments and the generation of actin rods [66].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [66]
In the citing paper
“In the hippocampus of individuals with Alzheimer’s disease and in animal models of Alzheimer’s disease, PAK activation is markedly reduced and mislocalized69.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
In the citing paper
“A critical regulator of actin assembly in spines is p21-activated kinase (PAK), a downstream effector molecule of Rac69,70.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Dendritic regression and spine loss per remaining neurite have been observed in Alzheimer disease with traditional Golgi stainin”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Aβ oligomers cause PAK signaling defects To directly test the hypothesis that Aβ oligomers can cause PAK signaling defects, we incubated cultured primary hippocampal neurons with 100 ng ml −1 of soluble Aβ1–42 aggregates prepared with an Aβ oligomer–generating protoco”
MethodAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498 · cited 1×
“Passive Aβ antibody treatment increases Tg2576 pPAK To further examine the possible role of Aβ in PAK deficits, we reduced the amount of Aβ with an approach that has been consistently demonstrated to clear Aβ and reverse cognitive deficits in App swe Tg mice—passive immunization with an anti-Aβ antibody recognizing th…”
BackgroundRegulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998) · Nature · doi:10.1038/31729 · Cited by 1,425 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundCofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization
Yang, N., Higuchi, O., Ohashi, K., Nagata, K., Wada, A., Kangawa, K., Nishida, E., & Mizuno, K. (1998) · Nature · doi:10.1038/31735 · Cited by 1,294 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“The accumulation of Aβ or the altered processing of its precursor amyloid precursor protein (APP), encoded by the gene App located on chromosome 21, is associated with Alzheimer disease; and increases in the App gene dosage resulting from complete or segmental trisomy 21 lead to early spine and cognitive deficits and,…”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · cited 1×
“Although it is possible that dendritic spine defects are merely secondary to upstream deficits in mental retardatio”
BackgroundCofilin Changes the Twist of F-Actin: Implications for Actin Filament Dynamics and Cellular Function
McGough, A., Pope, B., Chiu, W., & Weeds, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.771 · Cited by 761 · cited 1×
“In addition, cofilin induces conformational changes in actin that prevent other proteins from binding to acti”
BackgroundDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Self-citation
Cited by
Items 101–200 of 325
The Role of ADF/Cofilin in Synaptic Physiology and Alzheimer’s Disease
Ben Zablah, Y., Merovitch, N., & Jia, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.594998 · Cited by 69
“Despite low levels of total PAK in AD brains, phosphorylated active PAK is increased around Aβ deposits (Zhao et al., 2006).”
BackgroundInfluentialWoo, J. A., Boggess, T., Uhlar, C., Wang, X., Khan, H., Cappos, G., Joly-Amado, A., De Narvaez, E., Majid, S., Minamide, L. S., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.37 · Cited by 67
Echeverría, V., Burgess, S., Gamble‐George, J., Zeitlin, R., Lin, X., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.019 · Cited by 75
“For example, it has been described that A oligomers induce an abnormal activation of p21activated kinase (PAK), which parallels the development of synaptic dysfunction (McPhie et al., 2003; Matenia et al., 2005; Zhao et al., 2006; Ma et al., 2008; Nguyen et al., 2008; Salminen et al., 2008).”
BackgroundCofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer’s Disease
Kang, D. E., & Woo, J. A. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190585 · Cited by 67
Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration
Woo, J. A., Jung, A. R., Lakshmana, M. K., Bedrossian, A., Lim, Y., Bu, J. H., Park, S. A., Koo, E. H., Mook-Jung, I., & Kang, D. E. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.14 · Cited by 69
“Overexpression of active PAK reverses these effects of Ab oligomers.(22,23) Cofilin also has a key role in the loss of dendritic spines induced by Ab.”
Nair, R. R., Patil, S., Tiron, A., Kanhema, T., Panja, D., Schiro, L., Parobczak, K., Wilczynski, G., & Bramham, C. R. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00008 · Cited by 68
“As cofilin and drebrin are known to compete for binding to filaments (Zhao et al., 2006; Grintsevich and Reisler, 2014), it is possible that Arc impacts cofilin phosphorylation indirectly by modulating drebrin A activity.”
BackgroundWu, W., Du, S., Shi, W., Liu, Y., Hu, Y., Xie, Z., Yao, X., Liu, Z., Ma, W., Xu, L., et al. (2019) · Protein & Cell · doi:10.1007/s13238-019-0641-0 · Cited by 65
Mokhtar, S., Bakhuraysah, M. M., Cram, D. S., & Petratos, S. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/910502 · Cited by 87
“PAK also has two major isoforms, PAK1 and PAK3, and they have downstream signalling effects on Rho/Rac (for review see [61]).”
BackgroundBaglietto‐Vargas, D., Prieto, G. A., Limon, A., Forner, S., Rodriguez‐Ortiz, C. J., Ikemura, K., Ager, R. R., Medeiros, R., Trujillo‐Estrada, L., Martini, A. C., et al. (2018) · Aging Cell · doi:10.1111/acel.12791 · Cited by 65
ROCK, PAK, and Toll of synapses in Alzheimer’s disease
Salminen, A., Suuronen, T., & Kaarniranta, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.148 · Cited by 71
Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s Disease
Hottman, D. A., & Li, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8627-z · Cited by 61
“Aβ causes cellular dislocation and dysfunction of Rac and its effector protein PAK [74, 75].”
BackgroundCofilin Rods and Aggregates Concur with Tau Pathology and the Development of Alzheimer's Disease
Rahman, T., Davies, D. S., Tannenberg, R. K., Fok, S., Shepherd, C., Dodd, P. R., Cullen, K. M., & Goldsbury, C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140393 · Cited by 63
Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase
Barone, E., Mosser, S., & Fraering, P. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.004 · Cited by 72
Mouse Genetic Models of Human Brain Disorders
Leung, C., & Jia, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00040 · Cited by 69
“Group I PAKs are involved in multiple cellular processes particularly actin regulation, cell proliferation, apoptosis, and gene expression and alterations in PAK1–3 are associated with tumor formation, inflammation, and cognitive dysfunction (Kumar et al., 2006; Zhao et al., 2006).”
BackgroundPAKs in the brain: Function and dysfunction
Civiero, L., & Greggio, E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.005 · Cited by 66
The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders
Zhang, K., Wang, Y., Fan, T., Zeng, C., & Sun, Z. S. (2020) · Protein & Cell · doi:10.1007/s13238-020-00812-9 · Cited by 63
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
Cenini, G., Hebisch, M., Iefremova, V., Flitsch, L. J., Breitkreuz, Y., Tanzi, R. E., Kim, D. Y., Peitz, M., & Brüstle, O. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103568 · Cited by 56
Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines
Penzes, P., & Cahill, M. E. (2012) · Cytoskeleton · doi:10.1002/cm.21015 · Cited by 58
“Dysregulation of Pak has also been implicated in AD as a reduction in Pak protein expression and activity occurs in the forebrain of AD patients, and the rescue of Pak loss in a cellular AD model prevents the loss of postsynaptic proteins required for actin clustering [Zhao et al., 2006].”
Backgroundβ-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J. K., Klunk, W. E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.015 · Cited by 54
Funk, S. D., Yurdagul, A., Green, J. M., Jhaveri, K. A., Schwartz, M. A., & Orr, A. W. (2010) · Circulation Research · doi:10.1161/circresaha.109.210286 · Cited by 56
Emerging trends in the methodology of environmental toxicology: 3D cell culture and its applications
Wang, H., Xu, T., & Yin, D. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159501 · Cited by 61
Mapping of Drebrin Binding Site on F-Actin
Grintsevich, E. E., Galkin, V. E., Orlova, A., Ytterberg, A. J., Mikati, M., Kudryashov, D. S., Loo, J. A., Egelman, E. H., & Reisler, E. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.03.039 · Cited by 56
“9,10 According to in vitro studies, drebrin can be displaced from actin filaments by cofilin.(11) This observation is consistent with the finding that drebrin loss is accompanied by increased levels of cofilin in the brains of Alzheimer's disease patients.”
ResultKalirin and Trio: RhoGEFs in Synaptic Transmission, Plasticity, and Complex Brain Disorders
Paskus, J. D., Herring, B. E., & Roche, K. W. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.002 · Cited by 58
Nikolić, M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8032-1 · Cited by 56
“In confirmation, some of the molecular consequences of Aβ exposure, such as the decrease in drebin levels were prevented by the overexpression of active Pak1, suggesting that reduced Pak function may enhance neurodegenerative cytoskeletal pathologies [90].”
BackgroundResultInfluentialVenkataraman, L., Fair, S. R., McElroy, C. A., Hester, M. E., & Fu, H. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10068-9 · Cited by 56
The pathological interaction between diabetes and presymptomatic Alzheimer's disease
Burdo, J. R., Chen, Q., Calcutt, N. A., & Schubert, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.010 · Cited by 55
Wurz, A. I., Schulz, A. M., O’Bryant, C. T., Sharp, J. F., & Hughes, R. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.982074 · Cited by 56
“Drebrin’s actin-binding site shares sequence homology with cofilin’s actin-binding site and activated cofilin competes with Drebrin for actin binding in dendritic spines (Zhao et al., 2006).”
BackgroundGu, Z., Cheng, J., Zhong, P., Qin, L., Liu, W., & Yan, Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1204-14.2014 · Cited by 55
“Many studies have linked PAK/ cofilin/actin signaling defects and the ensuing abnormal neuronal connectivity and synaptic function to mental retardation (Allen et al., 1998; Ramakers, 2002; Hayashi et al., 2004) and AD (Minamide et al., 2000; Zhao et al., 2006).”
BackgroundMethodShaw, A. E., & Bamburg, J. R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.031 · Cited by 55
“…shifted from the norm in rodent models of many neurological disorders, including AD (Woo, Boggess, et al., 2015; Woo, Zhao, et al., 2015; Zhao et al., 2006), autism (Duffney et al., 2015; Liu et al., 2016), manic/bipolar disorder (Lee et al., 2016), sleep deprivation (Havekes et al.,…”
Mendoza-Naranjo, A., Contreras-Vallejos, E., Henriquez, D. R., Otth, C., Bamburg, J. R., Maccioni, R. B., & Gonzalez-Billault, C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-101575 · Cited by 51
“Reduced levels of PAK1 and PAK3 have been reported in AD brain [40].”
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
Guiler, W., Koehler, A., Boykin, C., & Lu, Q. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661612 · Cited by 51
“In AD, patient brains show diminished expression of Rac1 (Zhao et al., 2006).”
BackgroundDrebrin inhibits cofilin‐induced severing of F‐actin
Grintsevich, E. E., & Reisler, E. (2014) · Cytoskeleton · doi:10.1002/cm.21184 · Cited by 54
“Moreover, negative correlation between drebrin and cofilin levels in the brains of AD patients has been also reported [Zhao et al., 2006].”
BackgroundInfluentialIntercellular protein–protein interactions at synapses
Yang, X., Hou, D., Jiang, W., & Zhang, C. (2014) · Protein & Cell · doi:10.1007/s13238-014-0054-z · Cited by 58
“Moreover, Rac1, which is activated by EphA4-ICD, has been reported to control the activity of the p21-activated kinase (PAK) pathway, leading to memory impairment (Zhao et al., 2006).”
BackgroundPAK–PIX interactions regulate adhesion dynamics and membrane protrusion to control neurite outgrowth
Santiago‐Medina, M., Gregus, K. A., & Gómez, T. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.112607 · Cited by 51
“To begin to examine how PAK activity may influence growth cone motility, we used PAK18, a cell-permeable peptide inhibitor of PAK function (Maruta et al., 2002; Zhao et al., 2006).”
MethodDecreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology
Julien, C., Tremblay, C., Bendjelloul, F., Phivilay, A., Coulombe, M., Émond, V., & Calon, F. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21667 · Cited by 48
“This assumption is Journal of Neuroscience Research backed by data from cultured hippocampal cells as well as in vivo findings in which intracerebral injections of PAK inhibitors in rodents induce translocation of drebrin from the membrane to the cytosol (Zhao et al., 2006).”
BackgroundInfluentialSelf-citationKreis, P., Rousseau, V., Thévenot, E., Combeau, G., & Barnier, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05474.x · Cited by 51
“2004) and impairments of PAK function are associated with cognitive deficits in Alzheimer disease (Zhao et al. 2006).”
BackgroundAlberghina, L., & Colangelo, A. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-s1-s2 · Cited by 55
“Recently, a reduced PAK pathway was associated to cognitive deficits in AD [217].”
Backgroundp21-Activated kinase inhibitors: a patent review
Crawford, J. J., Hoeflich, K. P., & Rudolph, J. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.668758 · Cited by 50
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 60
“Interestingly, in both AD brains and in FAD-APP transgenic mice, affected neurons display increased accumulation of active PAK in the surroundings of Ab plaques (Ma et al., 2008; Zhao et al., 2006).”
Zhu, Y., Zhou, R., Yang, R., Zhang, Z., Bai, Y., Chang, F., Li, L., Sokabe, M., Goltzman, D., Miao, D., et al. (2010) · Hippocampus · doi:10.1002/hipo.20908 · Cited by 58
“This is supported by the recent findings that newborn neurons in the DG are integrated into hippocampal circuitry only after 4 to 8 weeks of maturation, during which dendritic spines contact perforant path synapses and the axons projecting into the CA3 area (Zhao et al., 2006; Toni et al., 2007).”
BackgroundResultMorikawa, M., Tanaka, Y., Cho, H., Yoshihara, M., & Hirokawa, N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.089 · Cited by 50
The Amyloid Precursor Protein Is a Conserved Receptor for Slit to Mediate Axon Guidance
Wang, B., Li, H., Mutlu, S. A., Bowser, D. A., Moore, M. J., Wang, M. C., & Zheng, H. (2017) · eneuro · doi:10.1523/eneuro.0185-17.2017 · Cited by 44
“, 2004) and may contribute to synaptic and cognitive deficits AD (Zhao et al., 2006).”
BackgroundThe Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis
Bolognin, S., Lorenzetto, E., Diana, G., & Buffelli, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8637-5 · Cited by 50
“during mild and late stage of the disease [103, 115, 116].”
BackgroundResultInfluentialTherapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
Labanca, F., Ullah, H., Khan, H. Z., Milella, L., Xiao, J., Stevanović, Z. D., & Jeandet, P. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200522201123 · Cited by 48
“Dysregulation of the p21-activated kinase (PAK) is associated with several neurodegenerative disorders [68, 69], as well as HD.”
BackgroundRho GTPases in neurodegeneration diseases
DeGeer, J., & Lamarche-Vane, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.016 · Cited by 46
Actin-binding protein drebrin E is involved in junction dynamics during spermatogenesis
Li, M., Xiao, X., Mruk, D. D., Lam, Y.-L., Lee, W. M., Lui, W., Bonanomi, M., Silvestrini, B., & Cheng, C. Y. (2011) · Spermatogenesis · doi:10.4161/spmg.1.2.16393 · Cited by 46
Majumdar, D., Nebhan, C. A., Hu, L., Anderson, B., & Webb, D. J. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.01.003 · Cited by 45
“Indeed, defects in PAK signaling are implicated in the cognitive decline and memory impairment associated with Alzheimer's disease (Zhao et al., 2006).”
BackgroundAβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer’s Disease
Henriques, A. G., Oliveira, J. M., Carvalho, L., & Silva, O. A. B. D. C. E. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8913-4 · Cited by 49
“Interestingly, the activation of cofilin leads to the rupture of actin-drebrin binding, resulting in loss of the latter spine actin-regulatory protein, suggesting that the balance between drebrin and cofilin activities is critical in spine dynamics modulation [42].”
BackgroundInfluentialAbnormal kalirin signaling in neuropsychiatric disorders
Remmers, C., Sweet, R. A., & Penzes, P. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.006 · Cited by 42
“A critical downstream effector of EphB2 and kalirin-7 ignaling, PAK, has also been associated with AD.”
BackgroundInfluentialDrebrin a content correlates with spine head size in the adult mouse cerebral cortex
Kobayashi, C., Aoki, C., Kojima, N., Yamazaki, H., & Shirao, T. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21408 · Cited by 43
“The studies using animal model of Alzheimer’s disease also indicate that drebrin level declines as the disease advances toward terminal symptoms (Calon et al., 2004; Zhao et al., 2006).”
ResultReutershan, J., Stockton, R. A., Zarbock, A., Sullivan, G. W., Chang, D., Scott, D., Schwartz, M. A., & Ley, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1822oc · Cited by 44
“A recent study suggested PAK’s involvement in Alzheimer disease ( 40 ).”
BackgroundSynaptic actin stabilization protein loss in Down syndrome and Alzheimer disease
Lauterborn, J. C., Cox, C. D., Chan, S. W., Vanderklish, P. W., Lynch, G., & Gall, C. M. (2020) · Brain Pathology · doi:10.1111/bpa.12779 · Cited by 43
“Reduced regional PAK levels are described for AD brains (40, 64), and decreased PAK expression in a triple transgenic AD mouse model has been associated with dendrite and spine defects (2).”
BackgroundInfluentialMcCarty, S., Saji, M., Zhang, X., Jarjoura, D. G., Fusco, A., Vasko, V. V., & Ringel, M. D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0168 · Cited by 43
“PAKs are direct downstream targets of Cdc42 and Rac, which organize actin and intermediate filaments, enhance growth, and inhibit apoptosis (Jaffer & Chernoff 2002, Bokoch 2003, Vadlamudi & Kumar 2003, Kumar et al. 2006, Zhao et al. 2006).”
BackgroundAlzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 47
Dun, X., & Chilton, J. K. (2010) · PubMed · doi:10.14670/hh-25.533 · Cited by 41
Actin and Actin-Binding Proteins: Masters of Dendritic Spine Formation, Morphology, and Function
Lin, W.-H., & Webb, D. J. (2009) · The Open Neuroscience Journal · doi:10.2174/1874082000903020054 · Cited by 40
“The loss of drebrin in the hippocampus of patients with Alzheimer's disease is paralleled with a significant increase in the amount of cofilin [184].”
Novel Mediators of Amyloid Precursor Protein Signaling
Swistowski, A., Zhang, Q., Orcholski, M. E., Crippen, D., Vitelli, C., Kurakin, A. V., & Bredesen, D. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4351-09.2009 · Cited by 41
“Recent, complementary results argue that signaling events, some of which are mediated by APP itself, also play a crucial role in the development of the AD phenotype (Galvan et al., 2006; Zhao et al., 2006; Townsend et al., 2007; Ma et al., 2008; Nguyen et al., 2008).”
BackgroundModelling Alzheimer's disease: Insights fromin vivotoin vitrothree-dimensional culture platforms
Ranjan, V., Qiu, L., Tan, E., Zeng, L., & Zhang, Y. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2728 · Cited by 46
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 38
Arsenault, D., Dal-Pan, A., Tremblay, C., Bennett, D. A., Guitton, M. J., De Koninck, Y., Tonegawa, S., & Calon, F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1501-13.2013 · Cited by 38
“In contrast, consistent with previous studies performed in AD patients and mouse models (Zhao et al., 2006; Kang et al., 2011), no changes in cofilin and phospho-cofilin concentrations were observed in our study.”
BackgroundResultSelf-citationKalirin Signaling: Implications for Synaptic Pathology
Penzes, P., & Remmers, C. L. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8223-z · Cited by 44
“Postmortem analysis of AD patient brains found that PAK protein and activation are markedly reduced and that phosphoPAK was mislocalized in the hippocampus of AD patients as well as in AD trans-genic mice [65].”
p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis
Zhao, Z., Park, C. J., McDevitt, M. A., Glidewell-Kenney, C., Chambon, P., Weiss, J., Jameson, J. L., & Levine, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812597106 · Cited by 38
“The PAK18 peptide but not the inactive peptide PAK18 R192A has been shown to reduce pPAK levels in the hippocampus by 80% after intracerebroventricular (icv) treatments, an effect that was accompanied by drebrin loss, cofilin pathology, and memory deficits (22).”
BackgroundMethodDrebrin preserves endothelial integrity by stabilizing nectin at adherens junctions
Rehm, K., Panzer, L., van Vliet, V., Genot, E. M., & Linder, S. (2013) · Journal of Cell Science · doi:10.1242/jcs.129437 · Cited by 39
Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Initial Segment
Costa, A. R., & Sousa, M. M. (2020) · Cells · doi:10.3390/cells9091961 · Cited by 42
Deng, Y., Wei, J., Cheng, J., Zhong, P., Zhe, X., Liu, A., Lin, L., Chen, S., & Yan, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160167 · Cited by 37
Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells
Horiguchi, A., Zheng, R., Shen, R., & Nanus, D. M. (2008) · The Prostate · doi:10.1002/pros.20760 · Cited by 35
“To test this hypothesis, DU145 cells were incubated with the PAK specific inhibitor PAK18 peptide [16,29] and its negative control PAK18R192A.”
BackgroundMethodIqbal, J., Zhang, K., Jin, N., Zhao, Y., Liu, Q., Ni, J., & Shen, L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00034 · Cited by 36
Rac-maninoff and Rho-vel: The symphony of Rho-GTPase signaling at excitatory synapses
Duman, J. G., Blanco, F. A., Cronkite, C. A., Ru, Q., Erikson, K., Mulherkar, S. A., Saifullah, A. B., Firozi, K., & Tolias, K. F. (2021) · Small GTPases · doi:10.1080/21541248.2021.1885264 · Cited by 39
Chan, P. M., & Manser, E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00011-0 · Cited by 38
p21-Activated kinase 1 (PAK1) in aging and longevity: An overview
Mohankumar, A., Sundararaj, P., & Tawata, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101443 · Cited by 36
Rac-Mediated Macropinocytosis Is a Critical Route for Naked Plasmid DNA Transfer in Mice
Fumoto, S., Nishi, J., Ishii, H., Wang, X., Miyamoto, H., Yoshikawa, N., Nakashima, M., Nakamura, J., & Nishida, K. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900042p · Cited by 37
Raman, D., Milatovic, S., Milatović, D., Splittgerber, R. C., Fan, G.-H., & Richmond, A. J. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.06.006 · Cited by 38
“Moreover, in the APP Swedish transgenic mouse model (Tg2576) loss of PAK1 and PAK3 contributes to defective dendritic spines and cognitive deficits and reduced expression and activity of PAK1 and PAK3 in temporal cortex and hippocampus correlated with concurrent loss of spine actin-regulatory protein drebrin (Zhao et…”
BackgroundInfluentialAdvances in the development of kinase inhibitor therapeutics for Alzheimer's disease
Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 39
“Pak apparently undergoes a biphasic increase, followed by decreased activity during the course of disease progression [Nguyen et al., 2008; Zhao et al., 2006; Hayashi et al., 2004], suggesting that homeostasis would be the goal, but probably difficult to target therapeutically.”
Caspase-12 Activation is Involved in Amyloid-β Protein-Induced Synaptic Toxicity
Quiroz‐Baez, R., Ferrera, P., Rosendo‐Gutiérrez, R., Morán, J., Bermúdez‐Rattoni, F., & Arias, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110326 · Cited by 34
“In both, AD and experimental models of AD, synaptic deterioration is commonly accompanied by loss of synaptic proteins such as synaptophysin [13,14,21], actin [19,22], and the actin-binding protein, debrin [23,24].”
Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression
Fuchsová, B., Juliá, A. A., Rizavi, H. S., Frasch, A. C. C., & Pandey, G. N. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.037 · Cited by 35
Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson’s disease
Won, S.-Y., Park, M.-H., You, S.-T., Choi, S.-W., Kim, H. K., McLean, C., Bae, S., Kim, S. R., Jin, B. K., Lee, K. H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1629 · Cited by 35
“Group I PAKs play vital roles in X-linked mental retardation (9, 53), fragile X syndrome (FXS) (54), and neurodegenerative diseases such as Alzheimer’s disease (55) and Huntington’s disease (7, 8).”
BackgroundDrebrin in Alzheimer’s Disease
Ishizuka, Y., & Hanamura, K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56550-5_12 · Cited by 35
Feng, J., Chen, S., Wang, Y., Liu, Q., Yang, M., Li, X., Nie, C., Qin, J., Chen, H., Yuan, X., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.03.094 · Cited by 36
Hochstrasser, T., Marksteiner, J., Defrancesco, M., Deisenhammer, E. A., Kemmler, G., & Humpel, C. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000330468 · Cited by 31
Actin and Diseases of the Nervous System
Bernstein, B. W., Maloney, M. T., & Bamburg, J. R. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7368-9_11 · Cited by 32
“elucidated, additional evidence for the role of Pak and actin regulatory proteins in cognitive disease comes from a study on Alzheimer’s disease (Zhao et al. 2006).”
BackgroundLight exposure before learning improves memory consolidation at night
Shan, L.-L., Guo, H., Song, N., Jia, Z., Hu, X., Huang, J., Ding, Y., Richter‐Levin, G., Zhou, Q., & Xu, L. (2015) · Scientific Reports · doi:10.1038/srep15578 · Cited by 31
Stefen, H., Chaichim, C., Power, J., & Fath, T. (2016) · Neural Plasticity · doi:10.1155/2016/2371970 · Cited by 33
“This pathway is supported by findings of decreased PAK1 in the brains of AD patients [209].”
ResultGordon‐Weeks, P. R. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.015 · Cited by 33
Distinct, but compensatory roles of PAK1 and PAK3 in spine morphogenesis
Boda, B., Jourdain, L., & Müller, D. (2008) · Hippocampus · doi:10.1002/hipo.20451 · Cited by 36
“…highly conserved p21-activated serine/threonine kinase (PAK) family participates in the regulation of cytoskeletal dynamics, and therefore is implicated in a wide range of physiological and pathological processes (Bokoch, 2003; van Galen and Ramakers, 2005; Zhao et al., 2006; Sheehan et al., 2007).”
BackgroundImplication of Rho GTPases in Neurodegenerative Diseases
Antoine-Bertrand, J., Villemure, J.-F., & Lamarche-Vane, N. (2011) · Current Drug Targets · doi:10.2174/138945011795906543 · Cited by 31
Neuronal adaptor FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1
Li, W., Tam, K. M. V., Chan, W. W. R., Koon, A. C., Ngo, J. C. K., Chan, H. Y. E., & Lau, K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000505 · Cited by 31
Importance of the Caspase Cleavage Site in Amyloid-β Protein Precursor
Bredesen, D. E., John, V., & Galvan, V. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100537 · Cited by 27
“This was of special interest since PAK had been shown to interact with the cytoplasmic domain of A β PP [45], and since PAK is a key contributor to dendritic spine morphology [44].”
Lunardi, P. S., Sachser, R. M., Sierra, R. O., Pedraza, L. K., Medina, C., de la Fuente, V., Romano, A. G., Quillfeldt, J. A., & Alvares, L. D. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0361-x · Cited by 33
“dendritic spine/synapse loss and memory deficits associated with Alzheimer’s disease [27, 28].”
BackgroundCeglia, I., Kim, Y., Nairn, A. C., & Greengard, P. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06743.x · Cited by 27
“Abnormal regulation of the actin cytoskeleton is associated with mental retardation (Newey et al. 2005) and cognitive deficits (Frangiskakis et al. 1996) as well as with neurodegenerative diseases (Minamide et al. 2000; Zhao et al. 2006).”
BackgroundMatsui, C., Inoue, E., Kakita, A., Arita, K., Deguchi‐Tawarada, M., Togawa, A., Yamada, A., Takai, Y., & Takahashi, H. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00587.x · Cited by 28
“The Rac signaling pathway has been reported to be down-regulated in the hippocampus of AD patients (27).”
BackgroundYasuoka, S., Kai, H., Kajimoto, H., Kudo, H., Takayama, N., Anegawa, T., Koga, M., Miyamoto, T., Mifune, H., Kage, M., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1253 · Cited by 27
Horvath, G. A., Tarailo‐Graovac, M., Bartel, T., Race, S., Allen, M. I. V., Blydt-Hansen, I., Ross, C. J., Wasserman, W. W., Connolly, M. B., & van Karnebeek, C. (2017) · Journal of Child Neurology · doi:10.1177/0883073817740443 · Cited by 29
“p21-activated serine/threonine kinases have been implicated in the pathophysiology of several neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.(20) PAK regulation is a complex process that involves homodimer and heterodimer formation.”
BackgroundMolecular mechanisms of altered adult hippocampal neurogenesis in Alzheimer's disease
Liu, H., Zhang, H., & Ma, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111452 · Cited by 27
Ishizuka, Y., Shimizu, H., Takagi, E., Kato, M., Yamagata, H., Mikuni, M., & Shirao, T. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.07.005 · Cited by 26
Han, F., Zhuang, T.-T., Chen, J., Zhu, X.-L., Cai, Y., & Lu, Y.-P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185102 · Cited by 27
Kang, D. E., Roh, S. E., Woo, J. A., Liu, T., Bu, J. H., Jung, A., & Lim, Y. (2011) · Experimental Neurobiology · doi:10.5607/en.2011.20.2.67 · Cited by 29
“Overexpression of active PAK reverses these effects of Aβ oligomers (Zhao et al., 2006; Ma et al., 2008).”
BackgroundDiChiara, T., DiNunno, N., Clark, J. R., Bu, R. L., Cline, E. N., Rollins, M. G., Gong, Y., Brody, D. L., Sligar, S. G., Velasco, P. T., et al. (2017) · PubMed Central · Cited by 32
Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 25
“Previous studies report neuronal and spine abnormalities in patients with AD [7-12, 45-48] and in the frontal cortex of 18-month-old hAPP mice, a transgenic mouse model of AD [46].”
BackgroundResultSelf-citationTau is actin up in Alzheimer's disease
Gallo, G. (2007) · Nature Cell Biology · doi:10.1038/ncb0207-133 · Cited by 25
Ansari, M. A., Rao, M. S. R., & Al‐Jarallah, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1273626 · Cited by 26
Metadata
- Authors
- Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., Weisbart, R. H., Teter, B., Frautschy, S. A., & Cole, G. M.
- Affiliations
- VA Sepulveda Ambulatory Care Center (US)
- University of California, Los Angeles (US)
- Centre hospitalier de l'Université Laval (CA)
- The University of Osaka (JP)
- Corresponding author
- Cole, Greg M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-01-15
- Volume
- 9
- Issue
- 2
- Pages
- 234-242
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1985086842
- Cited by
- 317
- References
- 52
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 22 · 2016: 16 · 2015: 9 · 2014: 20 · 2013: 22 · 2012: 23
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG16570, AG-10415, R01AG016793, P50AG016570, R01AG013741, P50-AG 16570, P50-AG05142, R01AG010685, AG022080, P60AG010415, P50AG005142, AG10685, AG16793, R01 AG13741, R01AG022080)
- National Institute of Neurological Disorders and Stroke (R01NS043946, NS43946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- p21-activated kinase, Alzheimer's disease, cognitive impairment, dendritic spines, cofilin, drebrin, actin dynamics, amyloid-beta, amyloid-beta oligomers, hippocampal neurons, memory impairment, synaptic dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Neuropeptides, Amyloid beta-Peptides, Protein Serine-Threonine Kinases, Dendritic Spines, Actin Depolymerizing Factors, Mice, Rats, p21-Activated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.